Aarkstore.com 2012 15% Discount || Oilfield Services Industry to 2016 - Technological || Latest
45 views | +0 today
Follow
Aarkstore.com 2012 15% Discount || Oilfield Services Industry to 2016 - Technological || Latest
GBI Research’s report, “Oilfield Services Industry to 2016 - Technological Advancements, Unconventional Plays, and Deepwater Activity to Drive the Market” provides key data, information and analysis on the global oilfield services industry.
Curated by Aarkstore.com
Your new post is loading...
Your new post is loading...
Scooped by Aarkstore.com
Scoop.it!

2012 || Pharmaceuticals || Aduro BioTech – Product Pipeline Review – 2012 || Aarkstore.com

2012 || Pharmaceuticals || Aduro BioTech – Product Pipeline Review – 2012 || Aarkstore.com | Aarkstore.com 2012 15% Discount || Oilfield Services Industry to 2016 - Technological || Latest | Scoop.it

Global Market Direct’s pharmaceuticals report, “Aduro BioTech - Product Pipeline
Review - 2012” provides data on the Aduro BioTech’s research and development
focus.

Aarkstore.com announces, The Latest  market research report is available in its vast collection:

Aduro BioTech – Product Pipeline Review – 2012 http://www.aarkstore.com/reports/Aduro-BioTech-Product-Pipeline-Review-2012-215266.html

RSS link of Global Markets Direct 
 http://www.aarkstore.com/feeds/Global-Markets-Direct.xml

Summary

Global Market Direct’s pharmaceuticals report, “Aduro BioTech - Product Pipeline Review - 2012” provides data on the Aduro BioTech’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Aduro BioTech’s corporate website, SEC filings, investor presentations and featured press releases, both from Aduro BioTech and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- Aduro BioTech - Brief Aduro BioTech overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Aduro BioTech human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.

Table of contents:

List of Tables 4
List of Figures 5
Aduro BioTech Snapshot 6
Aduro BioTech Overview 6
Key Information 6
Key Facts 6
Aduro BioTech – Research and Development Overview 7
Key Therapeutic Areas 7
Aduro BioTech – Pipeline Review 10
Pipeline Products by Stage of Development 10
Pipeline Products – Monotherapy 11
Pipeline Products – Combination Treatment Modalities 12
Aduro BioTech – Pipeline Products Glance 13
Aduro BioTech Clinical Stage Pipeline Products 13
Phase II Products/Combination Treatment Modalities 13
Phase I Products/Combination Treatment Modalities 14
Aduro BioTech – Early Stage Pipeline Products 15
Pre-Clinical Products/Combination Treatment Modalities 15
Discovery Products/Combination Treatment Modalities 16
Aduro BioTech – Drug Profiles 17
ANZ-100 17
Product Description 17
Mechanism of Action 17
R;D Progress 17
CRS-207 18
Product Description 18
Mechanism of Action 18
R;D Progress 18
GVAX Pancreas + Cyclophosphamide + CRS-207 20
Product Description 20
Mechanism of Action 20
R;D Progress 20
Lm Glioblastoma 22
Product Description 22
Mechanism of Action 22
R;D Progress 22
Lm HBV 23
Product Description 23
Mechanism of Action 23

List of Figures

List of Tables are also include.

 

For more related Reports Plz follow The link:

Pipeline Review, H1 2012
http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H1 2012&PubId=&pagenum=1

 

AC Immune SA – Product Pipeline Review – 2012

ActogeniX NV – Product Pipeline Review – 2012

Aduro BioTech – Product Pipeline Review – 2012

Advanced Cancer Therapeutics – Product Pipeline Review – 2012

Affectis Pharmaceuticals AG – Product Pipeline Review – 2012

Affimed Therapeutics AG – Product Pipeline Review – 2012

Affitech A/S – Product Pipeline Review – 2012

Curacyte AG – Product Pipeline Review – 2012

Allergan, Inc. – Product Pipeline Review – 2012

Alligator Bioscience AB – Product Pipeline Review – 2012

NeuroVive Pharmaceutical AB – Product Pipeline Review – 2012

Abiogen Pharma S.p.A. – Product Pipeline Review – 2012

 

Search More Reports Related to This Category :
 

Pharmaceuticals and Healthcare 
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and Healthcare&PubId=&pagenum=1



You can also request for sample page of above mention reports on sample@aarkstore.com





For More details Plz do contact :

Aarkstore Enterprise

Lavanya

Phone:08149852585

Email: enquiry@aarkstore.com

more...
No comment yet.
Scooped by Aarkstore.com
Scoop.it!

2012 || Pharmaceuticals ||AC Immune SA – Product Pipeline Review – 2012 || Aarkstore.com

2012 || Pharmaceuticals ||AC Immune SA – Product Pipeline Review – 2012 || Aarkstore.com | Aarkstore.com 2012 15% Discount || Oilfield Services Industry to 2016 - Technological || Latest | Scoop.it

Global Market Direct’s pharmaceuticals report, “AC Immune SA - Product Pipeline
Review - 2012” provides data on the AC Immune SA’s research and development
focus.

Aarkstore.com announces, The Latest  market research report is available in its vast collection:

AC Immune SA – Product Pipeline Review – 2012 http://www.aarkstore.com/reports/AC-Immune-SA-Product-Pipeline-Review-2012-215264.html


RSS link of Global Markets Direct 
 http://www.aarkstore.com/feeds/Global-Markets-Direct.xml

Summary

Global Market Direct’s pharmaceuticals report, “AC Immune SA - Product Pipeline Review - 2012” provides data on the AC Immune SA’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, AC Immune SA’s corporate website, SEC filings, investor presentations and featured press releases, both from AC Immune SA and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- AC Immune SA - Brief AC Immune SA overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of AC Immune SA human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.

Table of contents:

List of Tables 4
List of Figures 4
AC Immune SA Snapshot 5
AC Immune SA Overview 5
Key Information 5
Key Facts 5
AC Immune SA – Research and Development Overview 6
Key Therapeutic Areas 6
AC Immune SA – Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products – Monotherapy 9
AC Immune SA – Pipeline Products Glance 10
AC Immune SA Clinical Stage Pipeline Products 10
Phase II Products/Combination Treatment Modalities 10
Phase I Products/Combination Treatment Modalities 11
AC Immune SA – Early Stage Pipeline Products 12
Pre-Clinical Products/Combination Treatment Modalities 12
Discovery Products/Combination Treatment Modalities 13
AC Immune SA – Drug Profiles 14
ACI-24 14
Product Description 14
Mechanism of Action 14
R;D Progress 14
ACI-518 15
Product Description 15
Mechanism of Action 15
R;D Progress 15
ACI-636 16
Product Description 16
Mechanism of Action 16
R;D Progress 16
ACI-91 17
Product Description 17
Mechanism of Action 17
R;D Progress 17
Anti-Tau mAb 18
Product Description 18
Mechanism of Action 18


List of Figures

List of Tables are also include.

 

For more related Reports Plz follow The link:

Pipeline Review, H1 2012
http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H1 2012&PubId=&pagenum=1

 

AC Immune SA – Product Pipeline Review – 2012

ActogeniX NV – Product Pipeline Review – 2012

Aduro BioTech – Product Pipeline Review – 2012

Advanced Cancer Therapeutics – Product Pipeline Review – 2012

Affectis Pharmaceuticals AG – Product Pipeline Review – 2012

Affimed Therapeutics AG – Product Pipeline Review – 2012

Affitech A/S – Product Pipeline Review – 2012

Curacyte AG – Product Pipeline Review – 2012

Allergan, Inc. – Product Pipeline Review – 2012

Alligator Bioscience AB – Product Pipeline Review – 2012

NeuroVive Pharmaceutical AB – Product Pipeline Review – 2012

Abiogen Pharma S.p.A. – Product Pipeline Review – 2012

 

Search More Reports Related to This Category :
 

Pharmaceuticals and Healthcare 
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and Healthcare&PubId=&pagenum=1



You can also request for sample page of above mention reports on sample@aarkstore.com





For More details Plz do contact :

Aarkstore Enterprise

Lavanya

Phone:08149852585

Email: enquiry@aarkstore.com

more...
No comment yet.
Scooped by Aarkstore.com
Scoop.it!

2012 || Pharmaceuticals || House Dust Mite Allergy – Pipeline Review, H1 2012 || Aarkstore.com

2012 || Pharmaceuticals || House Dust Mite Allergy – Pipeline Review, H1 2012 || Aarkstore.com | Aarkstore.com 2012 15% Discount || Oilfield Services Industry to 2016 - Technological || Latest | Scoop.it

Global Markets Direct’s, House Dust Mite Allergy - Pipeline Review, H1 2012,
provides an overview of the House Dust Mite Allergy therapeutic pipeline.

Aarkstore.com announces, The Latest  market research report is available in its vast collection:


House Dust Mite Allergy – Pipeline Review, H1 2012


http://www.aarkstore.com/reports/House-Dust-Mite-Allergy-Pipeline-Review-H1-2012-215247.html

RSS link of Global Markets Direct 
 http://www.aarkstore.com/feeds/Global-Markets-Direct.xml



Summary

Global Markets Direct’s, House Dust Mite Allergy - Pipeline Review, H1 2012, provides an overview of the House Dust Mite Allergy therapeutic pipeline. This report provides information on the therapeutic development for House Dust Mite Allergy, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for House Dust Mite Allergy. House Dust Mite Allergy - Pipeline Review, H1 2012 is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for House Dust Mite Allergy.
- A review of the House Dust Mite Allergy products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.

Table of contents:

List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
House Dust Mite Allergy Overview 6
Therapeutics Development 7
An Overview of Pipeline Products for House Dust Mite Allergy 7
House Dust Mite Allergy Therapeutics under Development by Companies 9
Late Stage Products 10
Comparative Analysis 10
Mid Clinical Stage Products 11
Comparative Analysis 11
Early Clinical Stage Products 12
Comparative Analysis 12
Discovery and Pre-Clinical Stage Products 13
Comparative Analysis 13
House Dust Mite Allergy Therapeutics – Products under Development by Companies 14
Companies Involved in House Dust Mite Allergy Therapeutics Development 15
ALK-Abello A/S 15
Stallergenes S.A. 16
Allergopharma Joachim Ganzer KG 17
Circassia Holdings Ltd. 18
ImVisioN Therapeutics AG 19
Genetic Immunity, LLC 20
Biomay AG 21
House Dust Mite Allergy – Therapeutics Assessment 22
Assessment by Monotherapy Products 22
Assessment by Route of Administration 23
Assessment by Molecule Type 25
Drug Profiles 27
ToleroMune House Dust Mite T Cell Vaccine - Drug Profile 27
Product Description 27

List of Figures

List of Tables are also include.

 

For more related Reports Plz follow The link:

Pipeline Review, H1 2012
http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H1 2012&PubId=&pagenum=1



Corneal Neovascularization – Pipeline Review, H1 2012

Meningioma – Pipeline Review, H1 2012

Herpes Infections – Pipeline Review, H1 2012

House Dust Mite Allergy – Pipeline Review, H1 2012

Emesis (Vomiting) – Pipeline Review, H1 2012

Malignant Pleural Effusion – Pipeline Review, H1 2012

Primary Sclerosing Cholangitis – Pipeline Review, H1 2012

Dyspnea – Pipeline Review, H1 2012

Dental Pain – Pipeline Review, H1 2012

Circadian Rhythm Sleep Disorders – Pipeline Review, H1 2012

Pancreatitis – Pipeline Review, H1 2012

Gastric Ulcers – Pipeline Review, H1 2012



 

 

Search More Reports Related to This Category :
 

Pharmaceuticals and Healthcare 
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and Healthcare&PubId=&pagenum=1


You can also request for sample page of above mention reports on sample@aarkstore.com





For More details Plz do contact :

Aarkstore Enterprise

Lavanya

Phone:08149852585

Email: enquiry@aarkstore.com

more...
No comment yet.
Scooped by Aarkstore.com
Scoop.it!

2012 || Pharmaceuticals || Meningioma – Pipeline Review, H1 2012 || Aarkstore.com

2012 || Pharmaceuticals || Meningioma – Pipeline Review, H1 2012 || Aarkstore.com | Aarkstore.com 2012 15% Discount || Oilfield Services Industry to 2016 - Technological || Latest | Scoop.it

Global Markets Direct’s, Meningioma - Pipeline Review, H1 2012, provides an
overview of the Meningioma therapeutic pipeline.

Aarkstore.com announces, The Latest  market research report is available in its vast collection:


Meningococcemia (Meningococcal Infections) – Pipeline Review, H1 2012

http://www.aarkstore.com/reports/Meningococcemia-Meningococcal-Infections-Pipeline-Review-H1-2012-215225.html


RSS link of Global Markets Direct 
 http://www.aarkstore.com/feeds/Global-Markets-Direct.xml

Summary

Global Markets Direct’s, Meningococcemia (Meningococcal Infections) - Pipeline Review, H1 2012, provides an overview of the Meningococcemia (Meningococcal Infections) therapeutic pipeline. This report provides information on the therapeutic development for Meningococcemia (Meningococcal Infections), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Meningococcemia (Meningococcal Infections). Meningococcemia (Meningococcal Infections) - Pipeline Review, H1 2012 is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for Meningococcemia (Meningococcal Infections).
- A review of the Meningococcemia (Meningococcal Infections) products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.

Table of contents:

List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Meningococcemia (Meningococcal Infections) Overview 6
Therapeutics Development 7
An Overview of Pipeline Products for Meningococcemia (Meningococcal Infections) 7
Meningococcemia (Meningococcal Infections) Therapeutics under Development by Companies 9
Meningococcemia (Meningococcal Infections) Therapeutics under Investigation by Universities/Institutes 10
Late Stage Products 11
Comparative Analysis 11
Mid Clinical Stage Products 12
Comparative Analysis 12
Meningococcemia (Meningococcal Infections) Therapeutics – Products under Development by Companies 13
Meningococcemia (Meningococcal Infections) Therapeutics – Products under Investigation by Universities/Institutes 14
Companies Involved in Meningococcemia (Meningococcal Infections) Therapeutics Development 15
GlaxoSmithKline plc 15
Serum Institute of India Limited 16
Meningococcemia (Meningococcal Infections) – Therapeutics Assessment 17
Assessment by Monotherapy Products 17
Assessment by Combination Products 18
Assessment by Route of Administration 19

List of Figures

List of Tables are also include.

 

For more related Reports Plz follow The link:

Pipeline Review, H1 2012
http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H1 2012&PubId=&pagenum=1



Acute Promyelocytic Leukemia – Pipeline Review, H1 2012

Meningococcemia (Meningococcal Infections) – Pipeline Review, H1 2012

Diabetic Neuropathic Pain – Pipeline Review, H1 2012

Streptococcus Pneumoniae (Pneumococcus) Infections – Pipeline Review, H1 2012

Premature Labor (Tocolysis) – Pipeline Review, H1 2012

Wilms Tumor (Nephroblastoma) – Pipeline Review, H1 2012

Dry (Atrophic) Macular Degeneration – Pipeline Review, H1 2012

Chondrosarcoma – Pipeline Review, H1 2012

Cellulitis – Pipeline Review, H1 2012

Left Ventricular Dysfunction – Pipeline Review, H1 2012

Adenovirus Infections – Pipeline Review, H1 2012

Abscess – Pipeline Review, H1 2012

 

 

Search More Reports Related to This Category :
 

Pharmaceuticals and Healthcare 
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and Healthcare&PubId=&pagenum=1


You can also request for sample page of above mention reports on sample@aarkstore.com





For More details Plz do contact :

Aarkstore Enterprise

Lavanya

Phone:08149852585

Email: enquiry@aarkstore.com

more...
No comment yet.
Scooped by Aarkstore.com
Scoop.it!

2012 || Pharmaceuticals || General Anxiety Disorder – Pipeline Review, H1 2012 || Aarkstore.com

2012 || Pharmaceuticals || General Anxiety Disorder – Pipeline Review, H1 2012 || Aarkstore.com | Aarkstore.com 2012 15% Discount || Oilfield Services Industry to 2016 - Technological || Latest | Scoop.it

Global Markets Direct’s, General Anxiety Disorder - Pipeline Review, H1 2012,
provides an overview of the General Anxiety Disorder therapeutic pipeline.

Aarkstore.com announces, The Latest  market research report is available in its vast collection:


General Anxiety Disorder – Pipeline Review, H1 2012

http://www.aarkstore.com/reports/General-Anxiety-Disorder-Pipeline-Review-H1-2012-215238.html

RSS link of Global Markets Direct 
 http://www.aarkstore.com/feeds/Global-Markets-Direct.xml

Summary

Global Markets Direct’s, General Anxiety Disorder - Pipeline Review, H1 2012, provides an overview of the General Anxiety Disorder therapeutic pipeline. This report provides information on the therapeutic development for General Anxiety Disorder, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for General Anxiety Disorder. General Anxiety Disorder - Pipeline Review, H1 2012 is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for General Anxiety Disorder.
- A review of the General Anxiety Disorder products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.

Table of contents:

List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
General Anxiety Disorder Overview 6
Therapeutics Development 7
An Overview of Pipeline Products for General Anxiety Disorder 7
General Anxiety Disorder Therapeutics under Development by Companies 9
General Anxiety Disorder Therapeutics under Investigation by Universities/Institutes 10
Late Stage Products 11
Comparative Analysis 11
Mid Clinical Stage Products 12
Comparative Analysis 12
Early Clinical Stage Products 13
Comparative Analysis 13
Pre-Clinical Stage Products 14
Comparative Analysis 14
General Anxiety Disorder Therapeutics – Products under Development by Companies 15
General Anxiety Disorder Therapeutics – Products under Investigation by Universities/Institutes 16
Companies Involved in General Anxiety Disorder Therapeutics Development 17
H Lundbeck A/S 17
Addex Pharmaceuticals 18
Ironwood Pharmaceuticals, Inc. 19
General Anxiety Disorder – Therapeutics Assessment 20
Assessment by Monotherapy Products 20

List of Figures

List of Tables are also include.

 

For more related Reports Plz follow The link:

Pipeline Review, H1 2012
http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H1 2012&PubId=&pagenum=1



Obstructive Sleep Apnea – Pipeline Review, H1 2012

Eosinophilic Esophagitis – Pipeline Review, H1 2012

Microalbuminuria – Pipeline Review, H1 2012

Venous Leg Ulcers – Pipeline Review, H1 2012

General Anxiety Disorder – Pipeline Review, H1 2012

Brain Injury – Pipeline Review, H1 2012

Dilated Cardiomyopathy – Pipeline Review, H1 2012

Lymphoblastic Lymphoma – Pipeline Review, H1 2012

Pancreatitis – Pipeline Review, H1 2012

Gastric Ulcers – Pipeline Review, H1 2012



 

 

Search More Reports Related to This Category :
 

Pharmaceuticals and Healthcare 
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and Healthcare&PubId=&pagenum=1


You can also request for sample page of above mention reports on sample@aarkstore.com





For More details Plz do contact :

Aarkstore Enterprise

Lavanya

Phone:08149852585

Email: enquiry@aarkstore.com

more...
No comment yet.
Scooped by Aarkstore.com
Scoop.it!

2012 || Pharmaceuticals || Microalbuminuria – Pipeline Review, H1 2012 || Aarkstore.com

2012 || Pharmaceuticals || Microalbuminuria – Pipeline Review, H1 2012 || Aarkstore.com | Aarkstore.com 2012 15% Discount || Oilfield Services Industry to 2016 - Technological || Latest | Scoop.it

Global Markets Direct’s, Microalbuminuria - Pipeline Review, H1 2012, provides
an overview of the Microalbuminuria therapeutic pipeline.

Aarkstore.com announces, The Latest  market research report is available in its vast collection:

Microalbuminuria – Pipeline Review, H1 2012


http://www.aarkstore.com/reports/Microalbuminuria-Pipeline-Review-H1-2012-215236.html


RSS link of Global Markets Direct 
 http://www.aarkstore.com/feeds/Global-Markets-Direct.xml

Summary

Global Markets Direct’s, Microalbuminuria - Pipeline Review, H1 2012, provides an overview of the Microalbuminuria therapeutic pipeline. This report provides information on the therapeutic development for Microalbuminuria, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Microalbuminuria. Microalbuminuria - Pipeline Review, H1 2012 is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for Microalbuminuria.
- A review of the Microalbuminuria products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.

Table of contents:

List of Tables 3
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Microalbuminuria Overview 6
Therapeutics Development 7
An Overview of Pipeline Products for Microalbuminuria 7
Microalbuminuria Therapeutics under Development by Companies 9
Microalbuminuria Therapeutics under Investigation by Universities/Institutes 10
Late Stage Products 11
Comparative Analysis 11
Early Clinical Stage Products 12
Comparative Analysis 12
Microalbuminuria Therapeutics – Products under Development by Companies 13
Microalbuminuria Therapeutics – Products under Investigation by Universities/Institutes 14
Companies Involved in Microalbuminuria Therapeutics Development 15
FibroGen, Inc. 15
Microalbuminuria – Therapeutics Assessment 16
Assessment by Monotherapy Products 16
Assessment by Combination Products 17
Assessment by Route of Administration 18
Assessment by Molecule Type 20
Drug Profiles 22
FG-3019 - Drug Profile 22
Product Description 22
Mechanism of Action 22
R;D Progress 22
Benazepril - Drug Profile 24
Product Description 24
Mechanism of Action 24
R;D Progress 24
Valsartan - Drug Profile 26

List of Figures

List of Tables are also include.

 

For more related Reports Plz follow The link:

Pipeline Review, H1 2012
http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H1 2012&PubId=&pagenum=1



Obstructive Sleep Apnea – Pipeline Review, H1 2012

Eosinophilic Esophagitis – Pipeline Review, H1 2012

Microalbuminuria – Pipeline Review, H1 2012

Venous Leg Ulcers – Pipeline Review, H1 2012

General Anxiety Disorder – Pipeline Review, H1 2012

Brain Injury – Pipeline Review, H1 2012

Dilated Cardiomyopathy – Pipeline Review, H1 2012

Lymphoblastic Lymphoma – Pipeline Review, H1 2012

Pancreatitis – Pipeline Review, H1 2012

Gastric Ulcers – Pipeline Review, H1 2012



 

 

Search More Reports Related to This Category :
 

Pharmaceuticals and Healthcare 
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and Healthcare&PubId=&pagenum=1


You can also request for sample page of above mention reports on sample@aarkstore.com






For More details Plz do contact :

Aarkstore Enterprise

Lavanya

Phone:08149852585

Email: enquiry@aarkstore.com

more...
No comment yet.
Scooped by Aarkstore.com
Scoop.it!

2012 || Pharmaceuticals || Obstructive Sleep Apnea – Pipeline Review, H1 2012 || Aarkstore.com

2012 || Pharmaceuticals || Obstructive Sleep Apnea – Pipeline Review, H1 2012 || Aarkstore.com | Aarkstore.com 2012 15% Discount || Oilfield Services Industry to 2016 - Technological || Latest | Scoop.it

Global Markets Direct’s, Obstructive Sleep Apnea - Pipeline Review, H1 2012,
provides an overview of the Obstructive Sleep Apnea therapeutic pipeline.

Aarkstore.com announces, The Latest  market research report is available in its vast collection:


Obstructive Sleep Apnea – Pipeline Review, H1 2012

http://www.aarkstore.com/reports/Obstructive-Sleep-Apnea-Pipeline-Review-H1-2012-215234.html

RSS link of Global Markets Direct 
 http://www.aarkstore.com/feeds/Global-Markets-Direct.xml

Summary

Global Markets Direct’s, Obstructive Sleep Apnea - Pipeline Review, H1 2012, provides an overview of the Obstructive Sleep Apnea therapeutic pipeline. This report provides information on the therapeutic development for Obstructive Sleep Apnea, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Obstructive Sleep Apnea. Obstructive Sleep Apnea - Pipeline Review, H1 2012 is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for Obstructive Sleep Apnea.
- A review of the Obstructive Sleep Apnea products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.

Table of contents:

List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Obstructive Sleep Apnea Overview 6
Therapeutics Development 7
An Overview of Pipeline Products for Obstructive Sleep Apnea 7
Obstructive Sleep Apnea Therapeutics under Development by Companies 9
Obstructive Sleep Apnea Therapeutics under Investigation by Universities/Institutes 10
Late Stage Products 11
Comparative Analysis 11
Mid Clinical Stage Products 12
Comparative Analysis 12
Early Clinical Stage Products 13
Comparative Analysis 13
Obstructive Sleep Apnea Therapeutics – Products under Development by Companies 14
Obstructive Sleep Apnea Therapeutics – Products under Investigation by Universities/Institutes 15
Companies Involved in Obstructive Sleep Apnea Therapeutics Development 16
Merck ; Co., Inc. 16
Novo Nordisk A/S 17
VIVUS, Inc. 18
BIOPROJET SCR 19
Obstructive Sleep Apnea – Therapeutics Assessment 20
Assessment by Monotherapy Products 20
Assessment by Combination Products 21

List of Figures

List of Tables are also include.

 

For more related Reports Plz follow The link:

Pipeline Review, H1 2012
http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H1 2012&PubId=&pagenum=1



Obstructive Sleep Apnea – Pipeline Review, H1 2012

Eosinophilic Esophagitis – Pipeline Review, H1 2012

Microalbuminuria – Pipeline Review, H1 2012

Venous Leg Ulcers – Pipeline Review, H1 2012

General Anxiety Disorder – Pipeline Review, H1 2012

Brain Injury – Pipeline Review, H1 2012

Dilated Cardiomyopathy – Pipeline Review, H1 2012

Lymphoblastic Lymphoma – Pipeline Review, H1 2012

Pancreatitis – Pipeline Review, H1 2012

Gastric Ulcers – Pipeline Review, H1 2012



 

 

Search More Reports Related to This Category :
 

Pharmaceuticals and Healthcare 
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and Healthcare&PubId=&pagenum=1


You can also request for sample page of above mention reports on sample@aarkstore.com





For More details Plz do contact :

Aarkstore Enterprise

Lavanya

Phone:08149852585

Email: enquiry@aarkstore.com

more...
No comment yet.
Scooped by Aarkstore.com
Scoop.it!

2012 || Pharmaceuticals || Streptococcus Pneumoniae (Pneumococcus) Infections || Aarkstore.com

2012 || Pharmaceuticals || Streptococcus Pneumoniae (Pneumococcus) Infections || Aarkstore.com | Aarkstore.com 2012 15% Discount || Oilfield Services Industry to 2016 - Technological || Latest | Scoop.it

Global Markets Direct’s, Streptococcus Pneumoniae (Pneumococcus) Infections -
Pipeline Review, H1 2012, provides an overview of the Streptococcus Pneumoniae
(Pneumococcus) Infections therapeutic pipeline.

Aarkstore.com announces, The Latest  market research report is available in its vast collection:

Streptococcus Pneumoniae (Pneumococcus) Infections – Pipeline Review, H1 2012

http://www.aarkstore.com/reports/Streptococcus-Pneumoniae-Pneumococcus-Infections-Pipeline-Review-H1-2012-215227.html RSS link of Global Markets Direct 

 http://www.aarkstore.com/feeds/Global-Markets-Direct.xml

Summary

Global Markets Direct’s, Streptococcus Pneumoniae (Pneumococcus) Infections - Pipeline Review, H1 2012, provides an overview of the Streptococcus Pneumoniae (Pneumococcus) Infections therapeutic pipeline. This report provides information on the therapeutic development for Streptococcus Pneumoniae (Pneumococcus) Infections, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Streptococcus Pneumoniae (Pneumococcus) Infections. Streptococcus Pneumoniae (Pneumococcus) Infections - Pipeline Review, H1 2012 is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for Streptococcus Pneumoniae (Pneumococcus) Infections.
- A review of the Streptococcus Pneumoniae (Pneumococcus) Infections products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.

Table of contents:

List of Tables 6
List of Figures 7
Introduction 8
Global Markets Direct Report Coverage 8
Streptococcus Pneumoniae (Pneumococcus) Infections Overview 9
Therapeutics Development 10
An Overview of Pipeline Products for Streptococcus Pneumoniae (Pneumococcus) Infections 10
Streptococcus Pneumoniae (Pneumococcus) Infections Therapeutics under Development by Companies 12
Streptococcus Pneumoniae (Pneumococcus) Infections Therapeutics under Investigation by Universities/Institutes 15
Late Stage Products 16
Comparative Analysis 16
Mid Clinical Stage Products 17
Comparative Analysis 17
Early Clinical Stage Products 18
Comparative Analysis 18
Discovery and Pre-Clinical Stage Products 19
Comparative Analysis 19
Streptococcus Pneumoniae (Pneumococcus) Infections Therapeutics – Products under Development by Companies 20
Streptococcus Pneumoniae (Pneumococcus) Infections Therapeutics – Products under Investigation by Universities/Institutes 21
Companies Involved in Streptococcus Pneumoniae (Pneumococcus) Infections Therapeutics Development 22
GlaxoSmithKline plc 22
Merck ; Co., Inc. 23
ACE BioSciences A/S 24

List of Figures

List of Tables are also include.

 

For more related Reports Plz follow The link:

Pipeline Review, H1 2012
http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H1 2012&PubId=&pagenum=1



Acute Promyelocytic Leukemia – Pipeline Review, H1 2012

Meningococcemia (Meningococcal Infections) – Pipeline Review, H1 2012

Diabetic Neuropathic Pain – Pipeline Review, H1 2012

Streptococcus Pneumoniae (Pneumococcus) Infections – Pipeline Review, H1 2012

Premature Labor (Tocolysis) – Pipeline Review, H1 2012

Wilms Tumor (Nephroblastoma) – Pipeline Review, H1 2012

Dry (Atrophic) Macular Degeneration – Pipeline Review, H1 2012

Chondrosarcoma – Pipeline Review, H1 2012

Cellulitis – Pipeline Review, H1 2012

Left Ventricular Dysfunction – Pipeline Review, H1 2012

Adenovirus Infections – Pipeline Review, H1 2012

Abscess – Pipeline Review, H1 2012

 

 

Search More Reports Related to This Category :
 

Pharmaceuticals and Healthcare 
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and Healthcare&PubId=&pagenum=1


You can also request for sample page of above mention reports on sample@aarkstore.com





For More details Plz do contact :

Aarkstore Enterprise

Lavanya

Phone:08149852585

Email: enquiry@aarkstore.com

more...
No comment yet.
Scooped by Aarkstore.com
Scoop.it!

2012 || Pharmaceuticals || Meningococcemia (Meningococcal Infections) – Pipeline || Aarkstore.com

2012 || Pharmaceuticals || Meningococcemia (Meningococcal Infections) – Pipeline || Aarkstore.com | Aarkstore.com 2012 15% Discount || Oilfield Services Industry to 2016 - Technological || Latest | Scoop.it

Global Markets Direct’s, Meningococcemia (Meningococcal Infections) - Pipeline
Review, H1 2012, provides an overview of the Meningococcemia (Meningococcal
Infections) therapeutic pipeline.

Aarkstore.com announces, The Latest  market research report is available in its vast collection:


Meningococcemia (Meningococcal Infections) – Pipeline Review, H1 2012

http://www.aarkstore.com/reports/Meningococcemia-Meningococcal-Infections-Pipeline-Review-H1-2012-215225.html


RSS link of Global Markets Direct 
 http://www.aarkstore.com/feeds/Global-Markets-Direct.xml

Summary

Global Markets Direct’s, Meningococcemia (Meningococcal Infections) - Pipeline Review, H1 2012, provides an overview of the Meningococcemia (Meningococcal Infections) therapeutic pipeline. This report provides information on the therapeutic development for Meningococcemia (Meningococcal Infections), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Meningococcemia (Meningococcal Infections). Meningococcemia (Meningococcal Infections) - Pipeline Review, H1 2012 is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for Meningococcemia (Meningococcal Infections).
- A review of the Meningococcemia (Meningococcal Infections) products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.

Table of contents:

List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Meningococcemia (Meningococcal Infections) Overview 6
Therapeutics Development 7
An Overview of Pipeline Products for Meningococcemia (Meningococcal Infections) 7
Meningococcemia (Meningococcal Infections) Therapeutics under Development by Companies 9
Meningococcemia (Meningococcal Infections) Therapeutics under Investigation by Universities/Institutes 10
Late Stage Products 11
Comparative Analysis 11
Mid Clinical Stage Products 12
Comparative Analysis 12
Meningococcemia (Meningococcal Infections) Therapeutics – Products under Development by Companies 13
Meningococcemia (Meningococcal Infections) Therapeutics – Products under Investigation by Universities/Institutes 14
Companies Involved in Meningococcemia (Meningococcal Infections) Therapeutics Development 15
GlaxoSmithKline plc 15
Serum Institute of India Limited 16
Meningococcemia (Meningococcal Infections) – Therapeutics Assessment 17
Assessment by Monotherapy Products 17
Assessment by Combination Products 18
Assessment by Route of Administration 19

List of Figures

List of Tables are also include.

 

For more related Reports Plz follow The link:

Pipeline Review, H1 2012
http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H1 2012&PubId=&pagenum=1



Acute Promyelocytic Leukemia – Pipeline Review, H1 2012

Meningococcemia (Meningococcal Infections) – Pipeline Review, H1 2012

Diabetic Neuropathic Pain – Pipeline Review, H1 2012

Streptococcus Pneumoniae (Pneumococcus) Infections – Pipeline Review, H1 2012

Premature Labor (Tocolysis) – Pipeline Review, H1 2012

Wilms Tumor (Nephroblastoma) – Pipeline Review, H1 2012

Dry (Atrophic) Macular Degeneration – Pipeline Review, H1 2012

Chondrosarcoma – Pipeline Review, H1 2012

Cellulitis – Pipeline Review, H1 2012

Left Ventricular Dysfunction – Pipeline Review, H1 2012

Adenovirus Infections – Pipeline Review, H1 2012

Abscess – Pipeline Review, H1 2012

 

 

Search More Reports Related to This Category :
 

Pharmaceuticals and Healthcare 
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and Healthcare&PubId=&pagenum=1


You can also request for sample page of above mention reports on sample@aarkstore.com





For More details Plz do contact :

Aarkstore Enterprise

Lavanya

Phone:08149852585

Email: enquiry@aarkstore.com

more...
No comment yet.
Scooped by Aarkstore.com
Scoop.it!

Aarkstore Aarkstore 2012 10% Discount || Floating Production Storage and Offloading (FPSO) Industry || Aarkstore.com

Aarkstore Aarkstore 2012 10% Discount || Floating Production Storage and Offloading (FPSO) Industry || Aarkstore.com | Aarkstore.com 2012 15% Discount || Oilfield Services Industry to 2016 - Technological || Latest | Scoop.it

“Floating Production Storage and Offloading (FPSO) Industry - Global Market Analysis, Competitive Landscape and Planned Projects to 2015”, is the latest report from company, the industry analysis specialists, that provides an in-depth analysis of...

Aarkstore.com announces, The Latest  market research report is available in its vast collection:


Floating Production Storage and Offloading (FPSO) and Floating Storage and Offloading (FSO) Industry to 2016 - Rise of Deepwater Hydrocarbon Production Leading to Industry Growth



http://www.aarkstore.com/reports/Floating-Production-Storage-and-Offloading-FPSO-and-Floating-Storage-and-Offloading-FSO-Industry-to-2016-Rise-of-Deepwater-Hydrocarbon-Production-Leading-to-Industry-Growth-159235.html


RSS Link of GBI Research 
http://www.aarkstore.com/feeds/GBI.xml

Company announces 10% discount on this report.
 
Discount till 31th July 2012



Summary

Company, a leading business intelligence provider, has released its latest research, “Floating Production Storage and Offloading (FPSO) and Floating Storage and Offloading (FSO) Industry to 2016 - Rise of Deepwater Hydrocarbon Production Leading to Industry Growth”. The study, which is an offering from the company’s Energy Research Group, provides an in-depth analysis of the global FPSO and FSO industry highlighting the various concerns and shifting trends. The report provides a qualitative and quantitative analysis of the industry, citing the strategic incentives of the respective parties involved at various levels of the value chain. The report provides in-depth analysis of the key trends and challenges of relevance. The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Company’s team of industry experts.

Scope

The report provides in-depth analysis of the key factors affecting the FPSO and FSO industry globally. It also provides fleet information of importance. Its scope includes -
- Overview and analysis of the technological and contractual aspects of the FPSO Industry
- Key trends and challenges in the global FPSO and FSO industry
- Analysis by geography and company of current and expected annual production capacities

Table of contents:

1.1 List of Tables 8
1.2 List of Figures 11
2 Introduction - FPSO and FSO Industry to 2016 12
2.1 GBI Research Report Guidance 12
3 FPSOs and FSOs - A Fundamental Overview 13
3.1 The Evolution of FSOs and FPSOs 13
3.1.1 The Reasons for the Emergence 13
3.1.2 Important Historical Events 13
3.2 FPSO - Key Facilities 13
3.2.1 Processing 13
3.2.2 Storage 13
3.2.3 Offloading 14
3.3 Components and Systems of Key Utility 14
3.3.1 Mooring System 14
3.3.2 Risers 14
3.3.3 Turret 14
3.3.4 Topsides 15
3.3.5 Hull 15
3.3.6 Deck 15
3.4 The Significant Factors That Influence the Specifications of an FPSO or an FSO 15
3.4.1 Commodity Type 15
3.4.2 Field Specifications 15
3.4.3 Water Depth 16
3.4.4 Weather Conditions 16
3.5 Classification of FPSOs and FSOs 16
3.5.1 Vessel Classification by Shape 16
3.5.2 Vessel Classification by Hull Type 16
3.5.3 Vessel Classification by Build Type: New Build/Conversion 16
4 Business Strategy Perspective 17

List of Figures

List of Tables are also include.



For more DISCOUNT  related Reports Plz follow The link:

Contract Research Organizations (CROs) Market to 2018 - Public-Private Partnerships to Strengthen Research Capacities and Advance Clinical Development Programs

Ophthalmic Devices Market to 2017 - Glaucoma and Cataract Surgery Devices, Minimally Invasive Procedures in Ophthalmic Surgery to Drive the Ophthalmic Surgery Market

Down Stream Processing in Biopharmaceuticals - Increased Demand for Biologics Drives Improvement in Cost-effective Purification Technologies

Offshore Rig Construction Market to 2015 and Current Rig Deployment Scenario - Acquisition of Rivals a Prominent Strategic Option

Floating Production Storage and Offloading (FPSO) and Floating Storage and Offloading (FSO) Industry to 2016 - Rise of Deepwater Hydrocarbon Production Leading to Industry Growth

 

Search More Reports Related to This Category :

Oil & Gas
http://www.aarkstore.com/search/viewresults.asp?search=Oil & Gas&PubId=&pagenum=1


 

Natural Gas Industry to 2017 - Depleting Conventional Crude Oil Reserves and Emerging Technologies in Gas Consumption Infrastructure Driving Growth

Crude Oil Industry to 2016 - Deepwater Discoveries Worldwide and Rising Industrial Demand in Emerging Economies Driving the Industry

Oil and Gas Storage Industry to 2015 - Cost Reduction Strategies in the Form of Storage Facility Sharing to Boost the Market

Offshore Rig Construction Market to 2015 and Current Rig Deployment Scenario - Acquisition of Rivals a Prominent Strategic Option


You can also request for sample page of above mention reports on sample@aarkstore.com





For More details Plz do contact :

Aarkstore Enterprise

Lavanya

Phone:08149852585

Email: enquiry@aarkstore.com

more...
No comment yet.
Scooped by Aarkstore.com
Scoop.it!

Aarkstore Aarkstore 2012 10% Discount || Contract Research Organizations (CROs) Market to 2018 || Aarkstore.com

Aarkstore Aarkstore 2012 10% Discount || Contract Research Organizations (CROs) Market to 2018 || Aarkstore.com | Aarkstore.com 2012 15% Discount || Oilfield Services Industry to 2016 - Technological || Latest | Scoop.it

GBI Research, the leading business intelligence provider, has released its latest report, “Contract Research Organizations (CROs) Market to 2018 - Public-Private Partnerships to Strengthen Research Capacities and Advance Clinical Development Programs..

Aarkstore.com announces, The Latest  market research report is available in its vast collection:

Contract Research Organizations (CROs) Market to 2018 - Public-Private Partnerships to Strengthen Research Capacities and Advance Clinical Development Programs

http://www.aarkstore.com/reports/Contract-Research-Organizations-CROs-Market-to-2018-Public-Private-Partnerships-to-Strengthen-Research-Capacities-and-Advance-Clinical-Development-Programs-200528.html

RSS Link of GBI Research 
 http://www.aarkstore.com/feeds/GBI.xml


Company announces 10% discount on this report.

Discount till 31th July 2012


Summary

Company, the leading business intelligence provider, has released its latest report, “Contract Research Organizations (CROs) Market to 2018 - Public-Private Partnerships to Strengthen Research Capacities and Advance Clinical Development Programs”, which provides key data, information and analysis of CRO industry. The report provides a comprehensive insight into the size of the CRO market, and includes forecasts, key reasons for outsourcing, technology developments affecting CRO’s, public private partnerships, profiles of top CROs, drivers and restraints and deals analysis.

Scope

- Detailed overview of the CRO industry.
- Annualized market data and forecasts for the CRO market.
- Detailed overview of key reasons behind outsourcing, outsourcing service models and key drivers and restraints of the market.
- Analysis of the key technologies that affect CRO industry
- Analysis of public private partnerships with case studies.

Table of contents:

1 Table of Contents 4
1.1 List of Tables 7
1.2 List of Figures 8
2 Contract Research Organization Market to 2018 - Introduction 10
2.1 GBI Research Report Guidance 10
3 Contract Research Organization Market to 2018 - Overview 11
3.1 Global Contract Research Organizations 11
3.1.1 Clinical Research Process 11
3.1.2 Drug Discovery Phase 11
3.1.3 Pre-Clinical Phase 11
3.1.4 Phase I 11
3.1.5 Phase II 11
3.1.6 Phase III 11
3.1.7 Review and Approval from Regulatory Agencies 12
3.1.8 Post-marketing Studies 12
3.2 Key Reasons Outsourcing Clinical Trials and Research Processes 12
3.2.1 Different Strategies Adopted by the Pharmaceutical Companies to Increase the Efficiency 12
3.2.2 Increase in R&D Costs Compared to Revenue Growth 13
3.2.3 Increasing Drug Failure Rates a Concern for Pharmaceutical Companies 14
3.2.4 Less Time Required to Launch a Product in the Market 14
3.2.5 Outsourcing to Site Management Organizations 15

List of Figures

List of Tables are also include.


For more DISCOUNT  related Reports Plz follow The link:

Contract Research Organizations (CROs) Market to 2018 - Public-Private Partnerships to Strengthen Research Capacities and Advance Clinical Development Programs

Ophthalmic Devices Market to 2017 - Glaucoma and Cataract Surgery Devices, Minimally Invasive Procedures in Ophthalmic Surgery to Drive the Ophthalmic Surgery Market

Down Stream Processing in Biopharmaceuticals - Increased Demand for Biologics Drives Improvement in Cost-effective Purification Technologies

Offshore Rig Construction Market to 2015 and Current Rig Deployment Scenario - Acquisition of Rivals a Prominent Strategic Option

Floating Production Storage and Offloading (FPSO) and Floating Storage and Offloading (FSO) Industry to 2016 - Rise of Deepwater Hydrocarbon Production Leading to Industry Growth

 

Search More Reports Related to This Category :

Pharmaceuticals and Healthcare
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and Healthcare&PubId=&pagenum=1


 

Pharmaceutical Supply Chain in the US - Advances in RFID and ePedigree Systems to Limit Drug Counterfeits

Emerging Pharmaceutical Market in Brazil - Regulatory Framework Forces MNCs to Partner with Local Players Resulting in Profit and Control Sharing

Direct to Consumer (DTC) Advertising in Pharmaceuticals - Current and Future Market Outlook, Regulatory Landscape and Case Studies


You can also request for sample page of above mention reports on sample@aarkstore.com





For More details Plz do contact :

Aarkstore Enterprise

Lavanya

Phone:08149852585

Email: enquiry@aarkstore.com

.

more...
No comment yet.
Scooped by Aarkstore.com
Scoop.it!

2012 || Pharmaceuticals || Gastroesophageal (GE) Junction Carcinomas – Pipeline || Aarkstore.com

2012 || Pharmaceuticals || Gastroesophageal (GE) Junction Carcinomas – Pipeline || Aarkstore.com | Aarkstore.com 2012 15% Discount || Oilfield Services Industry to 2016 - Technological || Latest | Scoop.it

Global Markets Direct’s, Gastroesophageal (GE) Junction Carcinomas - Pipeline
Review, H1 2012, provides an overview of the Gastroesophageal (GE) Junction
Carcinomas therapeutic pipeline.

Aarkstore.com announces, The Latest  market research report is available in its vast collection:


Gastroesophageal (GE) Junction Carcinomas – Pipeline Review, H1 2012

http://www.aarkstore.com/reports/Gastroesophageal-GE-Junction-Carcinomas-Pipeline-Review-H1-2012-215219.html


RSS link of Global Markets Direct 
 http://www.aarkstore.com/feeds/Global-Markets-Direct.xml


Summary

Global Markets Direct’s, Gastroesophageal (GE) Junction Carcinomas - Pipeline Review, H1 2012, provides an overview of the Gastroesophageal (GE) Junction Carcinomas therapeutic pipeline. This report provides information on the therapeutic development for Gastroesophageal (GE) Junction Carcinomas, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Gastroesophageal (GE) Junction Carcinomas. Gastroesophageal (GE) Junction Carcinomas - Pipeline Review, H1 2012 is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for Gastroesophageal (GE) Junction Carcinomas.
- A review of the Gastroesophageal (GE) Junction Carcinomas products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.

Table of contents:

List of Tables 5
List of Figures 5
Introduction 6
Global Markets Direct Report Coverage 6
Gastroesophageal (GE) Junction Carcinomas Overview 7
Therapeutics Development 8
An Overview of Pipeline Products for Gastroesophageal (GE) Junction Carcinomas 8
Gastroesophageal (GE) Junction Carcinomas Therapeutics under Development by Companies 10
Gastroesophageal (GE) Junction Carcinomas Therapeutics under Investigation by Universities/Institutes 11
Mid Clinical Stage Products 13
Comparative Analysis 13
Early Clinical Stage Products 14
Comparative Analysis 14
Gastroesophageal (GE) Junction Carcinomas Therapeutics – Products under Development by Companies 15
Gastroesophageal (GE) Junction Carcinomas Therapeutics – Products under Investigation by Universities/Institutes 16
Companies Involved in Gastroesophageal (GE) Junction Carcinomas Therapeutics Development 17
Bristol-Myers Squibb Company 17
Amgen Inc. 18
AstraZeneca PLC 19
Eli Lilly and Company 20
Exelixis, Inc. 21
Ascenta Therapeutics, Inc. 22
Mebiopharm Co., Ltd. 23
Gastroesophageal (GE) Junction Carcinomas – Therapeutics Assessment 24
Assessment by Monotherapy Products 24

List of Figures

List of Tables are also include.

 

For more related Reports Plz follow The link:

Pipeline Review, H1 2012
http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H1 2012&PubId=&pagenum=1



Seasonal Allergic Rhinitis – Pipeline Review, H1 2012

Reperfusion Injury – Pipeline Review, H1 2012

Ulcers – Pipeline Review, H1 2012

Venous Leg Ulcers – Pipeline Review, H1 2012

Gestational Diabetes – Pipeline Review, H1 2012

Gastroesophageal (GE) Junction Carcinomas – Pipeline Review, H1 2012

Fanconi Anemia – Pipeline Review, H1 2012

Hepatitis D – Pipeline Review, H1 2012

Adult Malignant Glioma – Pipeline Review, H1 2012

Hemorrhage – Pipeline Review, H1 2012

Insulin Resistance – Pipeline Review, H1 2012

Adenovirus Infections – Pipeline Review, H1 2012

Abscess – Pipeline Review, H1 2012

 

 

Search More Reports Related to This Category :
 

Pharmaceuticals and Healthcare 
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and Healthcare&PubId=&pagenum=1


You can also request for sample page of above mention reports on sample@aarkstore.com





For More details Plz do contact :

Aarkstore Enterprise

Lavanya

Phone:08149852585

Email: enquiry@aarkstore.com

more...
No comment yet.
Scooped by Aarkstore.com
Scoop.it!

2012 || Pharmaceuticals || Ulcers – Pipeline Review, H1 2012 || Aarkstore.com

2012 || Pharmaceuticals || Ulcers – Pipeline Review, H1 2012 || Aarkstore.com | Aarkstore.com 2012 15% Discount || Oilfield Services Industry to 2016 - Technological || Latest | Scoop.it

Global Markets Direct’s, Ulcers - Pipeline Review, H1 2012, provides an
overview of the Ulcers therapeutic pipeline.

Aarkstore.com announces, The Latest  market research report is available in its vast collection:


Ulcers – Pipeline Review, H1 2012

http://www.aarkstore.com/reports/Ulcers-Pipeline-Review-H1-2012-215217.html

RSS link of Global Markets Direct 
 http://www.aarkstore.com/feeds/Global-Markets-Direct.xml


Summary

Global Markets Direct’s, Ulcers - Pipeline Review, H1 2012, provides an overview of the Ulcers therapeutic pipeline. This report provides information on the therapeutic development for Ulcers, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Ulcers. Ulcers - Pipeline Review, H1 2012 is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for Ulcers.
- A review of the Ulcers products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.

Table of contents:

List of Tables 5
List of Figures 6
Introduction 7
Global Markets Direct Report Coverage 7
Ulcers Overview 8
Therapeutics Development 9
An Overview of Pipeline Products for Ulcers 9
Ulcers Therapeutics under Development by Companies 11
Ulcers Therapeutics under Investigation by Universities/Institutes 13
Late Stage Products 14
Comparative Analysis 14
Mid Clinical Stage Products 15
Comparative Analysis 15
Early Clinical Stage Products 16
Comparative Analysis 16
Discovery and Pre-Clinical Stage Products 17
Comparative Analysis 17
Ulcers Therapeutics – Products under Development by Companies 18
Ulcers Therapeutics – Products under Investigation by Universities/Institutes 19
Companies Involved in Ulcers Therapeutics Development 20
Takeda Pharmaceutical Company Limited 20
Daewoong Pharmaceutical Co., Ltd. 21
Eisai Co., Ltd. 22
POZEN Inc. 23
Ahn-Gook Pharmaceutical Co., Ltd. 24
Sucampo Pharmaceuticals, Inc. 25
Angelini Group 26
PLx Pharma Inc. 27
HeliCure AB 28
Ulcers – Therapeutics Assessment 29
Assessment by Monotherapy Products 29
Assessment by Combination Products 30

List of Figures

List of Tables are also include.

 

For more related Reports Plz follow The link:

Pipeline Review, H1 2012
http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H1 2012&PubId=&pagenum=1



Seasonal Allergic Rhinitis – Pipeline Review, H1 2012

Reperfusion Injury – Pipeline Review, H1 2012

Ulcers – Pipeline Review, H1 2012

Venous Leg Ulcers – Pipeline Review, H1 2012

Gestational Diabetes – Pipeline Review, H1 2012

Gastroesophageal (GE) Junction Carcinomas – Pipeline Review, H1 2012

Fanconi Anemia – Pipeline Review, H1 2012

Hepatitis D – Pipeline Review, H1 2012

Adult Malignant Glioma – Pipeline Review, H1 2012

Hemorrhage – Pipeline Review, H1 2012

Insulin Resistance – Pipeline Review, H1 2012

Adenovirus Infections – Pipeline Review, H1 2012

Abscess – Pipeline Review, H1 2012

 

 

Search More Reports Related to This Category :
 

Pharmaceuticals and Healthcare 
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and Healthcare&PubId=&pagenum=1


You can also request for sample page of above mention reports on sample@aarkstore.com





For More details Plz do contact :

Aarkstore Enterprise

Lavanya

Phone:08149852585

Email: enquiry@aarkstore.com

more...
No comment yet.
Scooped by Aarkstore.com
Scoop.it!

2012 || Pharmaceuticals || ActogeniX NV – Product Pipeline Review – 2012 || Aarkstore.com

2012 || Pharmaceuticals || ActogeniX NV – Product Pipeline Review – 2012 || Aarkstore.com | Aarkstore.com 2012 15% Discount || Oilfield Services Industry to 2016 - Technological || Latest | Scoop.it

Global Market Direct’s pharmaceuticals report, “ActogeniX NV - Product Pipeline
Review - 2012” provides data on the ActogeniX NV’s research and development
focus.

Aarkstore.com announces, The Latest  market research report is available in its vast collection:

ActogeniX NV – Product Pipeline Review – 2012 http://www.aarkstore.com/reports/ActogeniX-NV-Product-Pipeline-Review-2012-215265.html


RSS link of Global Markets Direct 
 http://www.aarkstore.com/feeds/Global-Markets-Direct.xml

Summary

Global Market Direct’s pharmaceuticals report, “ActogeniX NV - Product Pipeline Review - 2012” provides data on the ActogeniX NV’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, ActogeniX NV’s corporate website, SEC filings, investor presentations and featured press releases, both from ActogeniX NV and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- ActogeniX NV - Brief ActogeniX NV overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of ActogeniX NV human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.

Table of contents:

List of Tables 4
List of Figures 4
ActogeniX NV Snapshot 5
ActogeniX NV Overview 5
Key Information 5
Key Facts 5
ActogeniX NV – Research and Development Overview 6
Key Therapeutic Areas 6
ActogeniX NV – Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products – Monotherapy 9
ActogeniX NV – Pipeline Products Glance 10
ActogeniX NV Clinical Stage Pipeline Products 10
Phase II Products/Combination Treatment Modalities 10
ActogeniX NV – Early Stage Pipeline Products 11
Pre-Clinical Products/Combination Treatment Modalities 11
Discovery Products/Combination Treatment Modalities 12
ActogeniX NV – Drug Profiles 13
ActoBiotic For Celiac Disease 13
Product Description 13
Mechanism of Action 13
R;D Progress 13
ActoBiotic For Clostridium Difficile Enteropathy 14
Product Description 14
Mechanism of Action 14
R;D Progress 14
ActoBiotics For Type 1 Diabetes 15
Product Description 15
Mechanism of Action 15
R;D Progress 15
ActoBiotics For Type 2 Diabetes 16
Product Description 16
Mechanism of Action 16
R;D Progress 16
ActoGeniX For Allergic Disease 17
Product Description 17

List of Figures

List of Tables are also include.

 

For more related Reports Plz follow The link:

Pipeline Review, H1 2012
http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H1 2012&PubId=&pagenum=1

 

AC Immune SA – Product Pipeline Review – 2012

ActogeniX NV – Product Pipeline Review – 2012

Aduro BioTech – Product Pipeline Review – 2012

Advanced Cancer Therapeutics – Product Pipeline Review – 2012

Affectis Pharmaceuticals AG – Product Pipeline Review – 2012

Affimed Therapeutics AG – Product Pipeline Review – 2012

Affitech A/S – Product Pipeline Review – 2012

Curacyte AG – Product Pipeline Review – 2012

Allergan, Inc. – Product Pipeline Review – 2012

Alligator Bioscience AB – Product Pipeline Review – 2012

NeuroVive Pharmaceutical AB – Product Pipeline Review – 2012

Abiogen Pharma S.p.A. – Product Pipeline Review – 2012

 

Search More Reports Related to This Category :
 

Pharmaceuticals and Healthcare 
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and Healthcare&PubId=&pagenum=1



You can also request for sample page of above mention reports on sample@aarkstore.com





For More details Plz do contact :

Aarkstore Enterprise

Lavanya

Phone:08149852585

Email: enquiry@aarkstore.com

more...
No comment yet.
Scooped by Aarkstore.com
Scoop.it!

2012 || Pharmaceuticals || Emesis (Vomiting) – Pipeline Review, H1 2012 || Aarkstore.com

2012 || Pharmaceuticals || Emesis (Vomiting) – Pipeline Review, H1 2012 || Aarkstore.com | Aarkstore.com 2012 15% Discount || Oilfield Services Industry to 2016 - Technological || Latest | Scoop.it

Global Markets Direct’s, House Dust Mite Allergy - Pipeline Review, H1 2012,
provides an overview of the House Dust Mite Allergy therapeutic pipeline.

Aarkstore.com announces, The Latest  market research report is available in its vast collection:

Emesis (Vomiting) – Pipeline Review, H1 2012

http://www.aarkstore.com/reports/Emesis-Vomiting-Pipeline-Review-H1-2012-215248.html


RSS link of Global Markets Direct 
 http://www.aarkstore.com/feeds/Global-Markets-Direct.xml

Summary

Global Markets Direct’s, Emesis (Vomiting) - Pipeline Review, H1 2012, provides an overview of the Emesis (Vomiting) therapeutic pipeline. This report provides information on the therapeutic development for Emesis (Vomiting), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Emesis (Vomiting). Emesis (Vomiting) - Pipeline Review, H1 2012 is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for Emesis (Vomiting).
- A review of the Emesis (Vomiting) products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.

Table of contents:

List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Emesis (Vomiting) Overview 6
Therapeutics Development 7
An Overview of Pipeline Products for Emesis (Vomiting) 7
Emesis (Vomiting) Therapeutics under Development by Companies 9
Emesis (Vomiting) Therapeutics under Investigation by Universities/Institutes 10
Late Stage Products 11
Comparative Analysis 11
Mid Clinical Stage Products 12
Comparative Analysis 12
Discovery and Pre-Clinical Stage Products 13
Comparative Analysis 13
Emesis (Vomiting) Therapeutics – Products under Development by Companies 14
Emesis (Vomiting) Therapeutics – Products under Investigation by Universities/Institutes 15
Companies Involved in Emesis (Vomiting) Therapeutics Development 16
ProStrakan Group plc 16
Ikano Therapeutics, Inc. 17
Sparsha Pharma International Pvt. Ltd. 18
Emesis (Vomiting) – Therapeutics Assessment 19
Assessment by Monotherapy Products 19
Assessment by Combination Products 20
Assessment by Route of Administration 21
Assessment by Molecule Type 23
Drug Profiles 25
Rolapitant - Drug Profile 25
Product Description 25
Mechanism of Action 25
R;D Progress 25
Antiemetic - Drug Profile 26

List of Figures

List of Tables are also include.

 

For more related Reports Plz follow The link:

Pipeline Review, H1 2012
http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H1 2012&PubId=&pagenum=1



Corneal Neovascularization – Pipeline Review, H1 2012

Meningioma – Pipeline Review, H1 2012

Herpes Infections – Pipeline Review, H1 2012

House Dust Mite Allergy – Pipeline Review, H1 2012

Emesis (Vomiting) – Pipeline Review, H1 2012

Malignant Pleural Effusion – Pipeline Review, H1 2012

Primary Sclerosing Cholangitis – Pipeline Review, H1 2012

Dyspnea – Pipeline Review, H1 2012

Dental Pain – Pipeline Review, H1 2012

Circadian Rhythm Sleep Disorders – Pipeline Review, H1 2012

Pancreatitis – Pipeline Review, H1 2012

Gastric Ulcers – Pipeline Review, H1 2012



 

 

Search More Reports Related to This Category :
 

Pharmaceuticals and Healthcare 
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and Healthcare&PubId=&pagenum=1


You can also request for sample page of above mention reports on sample@aarkstore.com





For More details Plz do contact :

Aarkstore Enterprise

Lavanya

Phone:08149852585

Email: enquiry@aarkstore.com

more...
No comment yet.
Scooped by Aarkstore.com
Scoop.it!

2012 || Pharmaceuticals || Herpes Infections – Pipeline Review, H1 2012 || Aarkstore.com

2012 || Pharmaceuticals || Herpes Infections – Pipeline Review, H1 2012 || Aarkstore.com | Aarkstore.com 2012 15% Discount || Oilfield Services Industry to 2016 - Technological || Latest | Scoop.it

Global Markets Direct’s, Herpes Infections - Pipeline Review, H1 2012,
provides an overview of the Herpes Infections therapeutic pipeline.

Aarkstore.com announces, The Latest  market research report is available in its vast collection:

Herpes Infections – Pipeline Review, H1 2012

http://www.aarkstore.com/reports/Herpes-Infections-Pipeline-Review-H1-2012-215246.html

RSS link of Global Markets Direct 
 http://www.aarkstore.com/feeds/Global-Markets-Direct.xml

Summary

Global Markets Direct’s, Herpes Infections - Pipeline Review, H1 2012, provides an overview of the Herpes Infections therapeutic pipeline. This report provides information on the therapeutic development for Herpes Infections, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Herpes Infections. Herpes Infections - Pipeline Review, H1 2012 is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for Herpes Infections.
- A review of the Herpes Infections products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.

Table of contents:

List of Tables 6
List of Figures 9
Introduction 10
Global Markets Direct Report Coverage 10
Herpes Infections Overview 11
Therapeutics Development 12
An Overview of Pipeline Products for Herpes Infections 12
Herpes Infections Therapeutics under Development by Companies 14
Herpes Infections Therapeutics under Investigation by Universities/Institutes 19
Late Stage Products 22
Comparative Analysis 22
Mid Clinical Stage Products 23
Comparative Analysis 23
Early Clinical Stage Products 24
Comparative Analysis 24
Discovery and Pre-Clinical Stage Products 25
Comparative Analysis 25
Herpes Infections Therapeutics – Products under Development by Companies 26
Herpes Infections Therapeutics – Products under Investigation by Universities/Institutes 30
Companies Involved in Herpes Infections Therapeutics Development 32
Bristol-Myers Squibb Company 32
Vical Incorporated 33
GlaxoSmithKline plc 34
Antigenics, Inc. 35
MedImmune LLC 36
Merck ; Co., Inc. 37
Novartis AG 38
Astellas Pharma Inc. 39
Alfacell Corporation 40
CEL-SCI Corporation 41
Mymetics Corporation 42
Nutra Pharma Corporation 43

List of Figures

List of Tables are also include.

 

For more related Reports Plz follow The link:

Pipeline Review, H1 2012
http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H1 2012&PubId=&pagenum=1



Corneal Neovascularization – Pipeline Review, H1 2012

Meningioma – Pipeline Review, H1 2012

Herpes Infections – Pipeline Review, H1 2012

House Dust Mite Allergy – Pipeline Review, H1 2012

Emesis (Vomiting) – Pipeline Review, H1 2012

Malignant Pleural Effusion – Pipeline Review, H1 2012

Primary Sclerosing Cholangitis – Pipeline Review, H1 2012

Dyspnea – Pipeline Review, H1 2012

Dental Pain – Pipeline Review, H1 2012

Circadian Rhythm Sleep Disorders – Pipeline Review, H1 2012

Pancreatitis – Pipeline Review, H1 2012

Gastric Ulcers – Pipeline Review, H1 2012



 

 

Search More Reports Related to This Category :
 

Pharmaceuticals and Healthcare 
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and Healthcare&PubId=&pagenum=1


You can also request for sample page of above mention reports on sample@aarkstore.com





For More details Plz do contact :

Aarkstore Enterprise

Lavanya

Phone:08149852585

Email: enquiry@aarkstore.com

more...
No comment yet.
Scooped by Aarkstore.com
Scoop.it!

2012 || Pharmaceuticals || Corneal Neovascularization – Pipeline Review, H1 2012 || Aarkstore.com

2012 || Pharmaceuticals || Corneal Neovascularization – Pipeline Review, H1 2012 || Aarkstore.com | Aarkstore.com 2012 15% Discount || Oilfield Services Industry to 2016 - Technological || Latest | Scoop.it

Global Markets Direct’s, Corneal Neovascularization - Pipeline Review, H1
2012, provides an overview of the Corneal Neovascularization therapeutic
pipeline.

Aarkstore.com announces, The Latest  market research report is available in its vast collection:


Corneal Neovascularization – Pipeline Review, H1 2012

http://www.aarkstore.com/reports/Corneal-Neovascularization-Pipeline-Review-H1-2012-215244.html

RSS link of Global Markets Direct 
 http://www.aarkstore.com/feeds/Global-Markets-Direct.xml

Summary

Global Markets Direct’s, Corneal Neovascularization - Pipeline Review, H1 2012, provides an overview of the Corneal Neovascularization therapeutic pipeline. This report provides information on the therapeutic development for Corneal Neovascularization, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Corneal Neovascularization. Corneal Neovascularization - Pipeline Review, H1 2012 is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for Corneal Neovascularization.
- A review of the Corneal Neovascularization products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.

Table of contents:

List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Corneal Neovascularization Overview 6
Therapeutics Development 7
An Overview of Pipeline Products for Corneal Neovascularization 7
Corneal Neovascularization Therapeutics under Development by Companies 9
Corneal Neovascularization Therapeutics under Investigation by Universities/Institutes 10
Late Stage Products 11
Comparative Analysis 11
Mid Clinical Stage Products 12
Comparative Analysis 12
Early Clinical Stage Products 13
Comparative Analysis 13
Pre-Clinical Stage Products 14
Comparative Analysis 14
Corneal Neovascularization Therapeutics – Products under Development by Companies 15
Corneal Neovascularization Therapeutics – Products under Investigation by Universities/Institutes 16
Companies Involved in Corneal Neovascularization Therapeutics Development 17
Sirnaomics, Inc. 17
Corneal Neovascularization – Therapeutics Assessment 18
Assessment by Monotherapy Products 18
Assessment by Route of Administration 19
Assessment by Molecule Type 21
Drug Profiles 23
Interleukin-1-Receptor Antagonist - Drug Profile 23
Product Description 23
Mechanism of Action 23
R;D Progress 23

List of Figures

List of Tables are also include.

 

For more related Reports Plz follow The link:

Pipeline Review, H1 2012
http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H1 2012&PubId=&pagenum=1



Corneal Neovascularization – Pipeline Review, H1 2012

Meningioma – Pipeline Review, H1 2012

Herpes Infections – Pipeline Review, H1 2012

House Dust Mite Allergy – Pipeline Review, H1 2012

Emesis (Vomiting) – Pipeline Review, H1 2012

Malignant Pleural Effusion – Pipeline Review, H1 2012

Primary Sclerosing Cholangitis – Pipeline Review, H1 2012

Dyspnea – Pipeline Review, H1 2012

Dental Pain – Pipeline Review, H1 2012

Circadian Rhythm Sleep Disorders – Pipeline Review, H1 2012

Pancreatitis – Pipeline Review, H1 2012

Gastric Ulcers – Pipeline Review, H1 2012



 

 

Search More Reports Related to This Category :
 

Pharmaceuticals and Healthcare 
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and Healthcare&PubId=&pagenum=1


You can also request for sample page of above mention reports on sample@aarkstore.com





For More details Plz do contact :

Aarkstore Enterprise

Lavanya

Phone:08149852585

Email: enquiry@aarkstore.com

more...
No comment yet.
Scooped by Aarkstore.com
Scoop.it!

2012 || Pharmaceuticals || Venous Leg Ulcers – Pipeline Review, H1 2012 || Aarkstore.com

2012 || Pharmaceuticals || Venous Leg Ulcers – Pipeline Review, H1 2012 || Aarkstore.com | Aarkstore.com 2012 15% Discount || Oilfield Services Industry to 2016 - Technological || Latest | Scoop.it

Global Markets Direct’s, Venous Leg Ulcers - Pipeline Review, H1 2012,
provides an overview of the Venous Leg Ulcers therapeutic pipeline.

Aarkstore.com announces, The Latest  market research report is available in its vast collection:


Venous Leg Ulcers – Pipeline Review, H1 2012 http://www.aarkstore.com/reports/Venous-Leg-Ulcers-Pipeline-Review-H1-2012-215237.html

RSS link of Global Markets Direct 
 http://www.aarkstore.com/feeds/Global-Markets-Direct.xml

Summary

Global Markets Direct’s, Venous Leg Ulcers - Pipeline Review, H1 2012, provides an overview of the Venous Leg Ulcers therapeutic pipeline. This report provides information on the therapeutic development for Venous Leg Ulcers, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Venous Leg Ulcers. Venous Leg Ulcers - Pipeline Review, H1 2012 is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for Venous Leg Ulcers.
- A review of the Venous Leg Ulcers products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.

Table of contents:

List of Tables 4
List of Figures 5
Introduction 6
Global Markets Direct Report Coverage 6
Venous Leg Ulcers Overview 7
Therapeutics Development 8
An Overview of Pipeline Products for Venous Leg Ulcers 8
Venous Leg Ulcers Therapeutics under Development by Companies 10
Venous Leg Ulcers Therapeutics under Investigation by Universities/Institutes 12
Late Stage Products 13
Comparative Analysis 13
Mid Clinical Stage Products 14
Comparative Analysis 14
Early Clinical Stage Products 15
Comparative Analysis 15
Pre-Clinical Stage Products 16
Comparative Analysis 16
Venous Leg Ulcers Therapeutics – Products under Development by Companies 17
Venous Leg Ulcers Therapeutics – Products under Investigation by Universities/Institutes 18
Companies Involved in Venous Leg Ulcers Therapeutics Development 19
Sanofi-Aventis 19
CytoTools AG 20
Healthpoint, Ltd. 21
Glycotex, Inc. 22
Phage Biotechnology Corporation 23
CoDa Therapeutics, Inc. 24
Adocia 25
Venous Leg Ulcers – Therapeutics Assessment 26
Assessment by Monotherapy Products 26
Assessment by Route of Administration 27

List of Figures

List of Tables are also include.

 

For more related Reports Plz follow The link:

Pipeline Review, H1 2012
http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H1 2012&PubId=&pagenum=1



Obstructive Sleep Apnea – Pipeline Review, H1 2012

Eosinophilic Esophagitis – Pipeline Review, H1 2012

Microalbuminuria – Pipeline Review, H1 2012

Venous Leg Ulcers – Pipeline Review, H1 2012

General Anxiety Disorder – Pipeline Review, H1 2012

Brain Injury – Pipeline Review, H1 2012

Dilated Cardiomyopathy – Pipeline Review, H1 2012

Lymphoblastic Lymphoma – Pipeline Review, H1 2012

Pancreatitis – Pipeline Review, H1 2012

Gastric Ulcers – Pipeline Review, H1 2012



 

 

Search More Reports Related to This Category :
 

Pharmaceuticals and Healthcare 
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and Healthcare&PubId=&pagenum=1


You can also request for sample page of above mention reports on sample@aarkstore.com





For More details Plz do contact :

Aarkstore Enterprise

Lavanya

Phone:08149852585

Email: enquiry@aarkstore.com

more...
No comment yet.
Scooped by Aarkstore.com
Scoop.it!

2012 || Pharmaceuticals || Eosinophilic Esophagitis – Pipeline Review, H1 2012 || Aarkstore.com

2012 || Pharmaceuticals || Eosinophilic Esophagitis – Pipeline Review, H1 2012 || Aarkstore.com | Aarkstore.com 2012 15% Discount || Oilfield Services Industry to 2016 - Technological || Latest | Scoop.it

Global Markets Direct’s, Eosinophilic Esophagitis - Pipeline Review, H1 2012,
provides an overview of the Eosinophilic Esophagitis therapeutic pipeline.

Aarkstore.com announces, The Latest  market research report is available in its vast collection:


Eosinophilic Esophagitis – Pipeline Review, H1 2012

http://www.aarkstore.com/reports/Eosinophilic-Esophagitis-Pipeline-Review-H1-2012-215235.html

RSS link of Global Markets Direct 
 http://www.aarkstore.com/feeds/Global-Markets-Direct.xml

Summary

Global Markets Direct’s, Eosinophilic Esophagitis - Pipeline Review, H1 2012, provides an overview of the Eosinophilic Esophagitis therapeutic pipeline. This report provides information on the therapeutic development for Eosinophilic Esophagitis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Eosinophilic Esophagitis. Eosinophilic Esophagitis - Pipeline Review, H1 2012 is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for Eosinophilic Esophagitis.
- A review of the Eosinophilic Esophagitis products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.

Table of contents:

List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Eosinophilic Esophagitis Overview 6
Therapeutics Development 7
An Overview of Pipeline Products for Eosinophilic Esophagitis 7
Eosinophilic Esophagitis Therapeutics under Development by Companies 9
Eosinophilic Esophagitis Therapeutics under Investigation by Universities/Institutes 10
Late Stage Products 11
Comparative Analysis 11
Mid Clinical Stage Products 12
Comparative Analysis 12
Early Clinical Stage Products 13
Comparative Analysis 13
Eosinophilic Esophagitis Therapeutics – Products under Development by Companies 14
Eosinophilic Esophagitis Therapeutics – Products under Investigation by Universities/Institutes 15
Companies Involved in Eosinophilic Esophagitis Therapeutics Development 16
Novartis AG 16
Axcan Pharma Inc. 17
Cephalon, Inc. 18
Meritage Pharma, Inc. 19
Oxagen Limited 20
Eosinophilic Esophagitis – Therapeutics Assessment 21
Assessment by Monotherapy Products 21
Assessment by Route of Administration 22
Assessment by Molecule Type 24
Drug Profiles 26
Cinquil - Drug Profile 26
Product Description 26

List of Figures

List of Tables are also include.

 

For more related Reports Plz follow The link:

Pipeline Review, H1 2012
http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H1 2012&PubId=&pagenum=1



Obstructive Sleep Apnea – Pipeline Review, H1 2012

Eosinophilic Esophagitis – Pipeline Review, H1 2012

Microalbuminuria – Pipeline Review, H1 2012

Venous Leg Ulcers – Pipeline Review, H1 2012

General Anxiety Disorder – Pipeline Review, H1 2012

Brain Injury – Pipeline Review, H1 2012

Dilated Cardiomyopathy – Pipeline Review, H1 2012

Lymphoblastic Lymphoma – Pipeline Review, H1 2012

Pancreatitis – Pipeline Review, H1 2012

Gastric Ulcers – Pipeline Review, H1 2012



 

 

Search More Reports Related to This Category :
 

Pharmaceuticals and Healthcare 
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and Healthcare&PubId=&pagenum=1


You can also request for sample page of above mention reports on sample@aarkstore.com





For More details Plz do contact :

Aarkstore Enterprise

Lavanya

Phone:08149852585

Email: enquiry@aarkstore.com

more...
No comment yet.
Scooped by Aarkstore.com
Scoop.it!

2012 || Pharmaceuticals || Premature Labor (Tocolysis) – Pipeline Review, H1 2012 || Aarkstore.com

2012 || Pharmaceuticals || Premature Labor (Tocolysis) – Pipeline Review, H1 2012 || Aarkstore.com | Aarkstore.com 2012 15% Discount || Oilfield Services Industry to 2016 - Technological || Latest | Scoop.it

Global Markets Direct’s, Premature Labor (Tocolysis) - Pipeline Review, H1
2012, provides an overview of the Premature Labor (Tocolysis) therapeutic
pipeline.

Aarkstore.com announces, The Latest  market research report is available in its vast collection:


Premature Labor (Tocolysis) – Pipeline Review, H1 2012 http://www.aarkstore.com/reports/Premature-Labor-Tocolysis-Pipeline-Review-H1-2012-215228.html

RSS link of Global Markets Direct 
 http://www.aarkstore.com/feeds/Global-Markets-Direct.xml

Summary

Global Markets Direct’s, Premature Labor (Tocolysis) - Pipeline Review, H1 2012, provides an overview of the Premature Labor (Tocolysis) therapeutic pipeline. This report provides information on the therapeutic development for Premature Labor (Tocolysis), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Premature Labor (Tocolysis). Premature Labor (Tocolysis) - Pipeline Review, H1 2012 is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for Premature Labor (Tocolysis).
- A review of the Premature Labor (Tocolysis) products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined
therapeutics.

Table of contents:

List of Tables 4
List of Figures 5
Introduction 6
Global Markets Direct Report Coverage 6
Premature Labor (Tocolysis) Overview 7
Therapeutics Development 8
An Overview of Pipeline Products for Premature Labor (Tocolysis) 8
Premature Labor (Tocolysis) Therapeutics under Development by Companies 10
Premature Labor (Tocolysis) Therapeutics under Investigation by Universities/Institutes 11
Late Stage Products 12
Comparative Analysis 12
Mid Clinical Stage Products 13
Comparative Analysis 13
Pre-Clinical Stage Products 14
Comparative Analysis 14
Premature Labor (Tocolysis) Therapeutics – Products under Development by Companies 15
Premature Labor (Tocolysis) Therapeutics – Products under Investigation by Universities/Institutes 16
Companies Involved in Premature Labor (Tocolysis) Therapeutics Development 17
GlaxoSmithKline plc 17
Watson Pharmaceuticals, Inc. 18
Kissei Pharmaceutical Co., Ltd. 19
PDC Biotech GmbH 20
Ferring Pharmaceuticals, Inc. 21
Premature Labor (Tocolysis) – Therapeutics Assessment 22
Assessment by Monotherapy Products 22


List of Figures

List of Tables are also include.

 

For more related Reports Plz follow The link:

Pipeline Review, H1 2012
http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H1 2012&PubId=&pagenum=1



Acute Promyelocytic Leukemia – Pipeline Review, H1 2012

Meningococcemia (Meningococcal Infections) – Pipeline Review, H1 2012

Diabetic Neuropathic Pain – Pipeline Review, H1 2012

Streptococcus Pneumoniae (Pneumococcus) Infections – Pipeline Review, H1 2012

Premature Labor (Tocolysis) – Pipeline Review, H1 2012

Wilms Tumor (Nephroblastoma) – Pipeline Review, H1 2012

Dry (Atrophic) Macular Degeneration – Pipeline Review, H1 2012

Chondrosarcoma – Pipeline Review, H1 2012

Cellulitis – Pipeline Review, H1 2012

Left Ventricular Dysfunction – Pipeline Review, H1 2012

Adenovirus Infections – Pipeline Review, H1 2012

Abscess – Pipeline Review, H1 2012

 

 

Search More Reports Related to This Category :
 

Pharmaceuticals and Healthcare 
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and Healthcare&PubId=&pagenum=1


You can also request for sample page of above mention reports on sample@aarkstore.com





For More details Plz do contact :

Aarkstore Enterprise

Lavanya

Phone:08149852585

Email: enquiry@aarkstore.com

more...
No comment yet.
Scooped by Aarkstore.com
Scoop.it!

2012 || Pharmaceuticals || Diabetic Neuropathic Pain – Pipeline Review, H1 2012 || Aarkstore.com

2012 || Pharmaceuticals || Diabetic Neuropathic Pain – Pipeline Review, H1 2012 || Aarkstore.com | Aarkstore.com 2012 15% Discount || Oilfield Services Industry to 2016 - Technological || Latest | Scoop.it

Global Markets Direct’s, Diabetic Neuropathic Pain - Pipeline Review, H1 2012,
provides an overview of the Diabetic Neuropathic Pain therapeutic pipeline

Aarkstore.com announces, The Latest  market research report is available in its vast collection:


Diabetic Neuropathic Pain – Pipeline Review, H1 2012 http://www.aarkstore.com/reports/Diabetic-Neuropathic-Pain-Pipeline-Review-H1-2012-215226.html

RSS link of Global Markets Direct 
 http://www.aarkstore.com/feeds/Global-Markets-Direct.xml

Summary

Global Markets Direct’s, Diabetic Neuropathic Pain - Pipeline Review, H1 2012, provides an overview of the Diabetic Neuropathic Pain therapeutic pipeline. This report provides information on the therapeutic development for Diabetic Neuropathic Pain, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Diabetic Neuropathic Pain. Diabetic Neuropathic Pain - Pipeline Review, H1 2012 is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for Diabetic Neuropathic Pain.
- A review of the Diabetic Neuropathic Pain products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.

Table of contents:

List of Tables 5
List of Figures 6
Introduction 7
Global Markets Direct Report Coverage 7
Diabetic Neuropathic Pain Overview 8
Therapeutics Development 9
An Overview of Pipeline Products for Diabetic Neuropathic Pain 9
Diabetic Neuropathic Pain Therapeutics under Development by Companies 11
Diabetic Neuropathic Pain Therapeutics under Investigation by Universities/Institutes 13
Late Stage Products 14
Comparative Analysis 14
Mid Clinical Stage Products 15
Comparative Analysis 15
Early Clinical Stage Products 16
Comparative Analysis 16
Discovery and Pre-Clinical Stage Products 17
Comparative Analysis 17
Diabetic Neuropathic Pain Therapeutics – Products under Development by Companies 18
Diabetic Neuropathic Pain Therapeutics – Products under Investigation by Universities/Institutes 19
Companies Involved in Diabetic Neuropathic Pain Therapeutics Development 20
Bristol-Myers Squibb Company 20
Abbott Laboratories 21
EpiCept Corporation 22
AVANIR Pharmaceuticals 23
Diamyd Medical AB 24
Proximagen Neuroscience plc. 25


List of Figures

List of Tables are also include.

 

For more related Reports Plz follow The link:

Pipeline Review, H1 2012
http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H1 2012&PubId=&pagenum=1



Acute Promyelocytic Leukemia – Pipeline Review, H1 2012

Meningococcemia (Meningococcal Infections) – Pipeline Review, H1 2012

Diabetic Neuropathic Pain – Pipeline Review, H1 2012

Streptococcus Pneumoniae (Pneumococcus) Infections – Pipeline Review, H1 2012

Premature Labor (Tocolysis) – Pipeline Review, H1 2012

Wilms Tumor (Nephroblastoma) – Pipeline Review, H1 2012

Dry (Atrophic) Macular Degeneration – Pipeline Review, H1 2012

Chondrosarcoma – Pipeline Review, H1 2012

Cellulitis – Pipeline Review, H1 2012

Left Ventricular Dysfunction – Pipeline Review, H1 2012

Adenovirus Infections – Pipeline Review, H1 2012

Abscess – Pipeline Review, H1 2012

 

 

Search More Reports Related to This Category :
 

Pharmaceuticals and Healthcare 
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and Healthcare&PubId=&pagenum=1


You can also request for sample page of above mention reports on sample@aarkstore.com





For More details Plz do contact :

Aarkstore Enterprise

Lavanya

Phone:08149852585

Email: enquiry@aarkstore.com

.

more...
No comment yet.
Scooped by Aarkstore.com
Scoop.it!

2012 || Pharmaceuticals || Acute Promyelocytic Leukemia – Pipeline Review, H1 2012 || Aarkstore.com

2012 || Pharmaceuticals || Acute Promyelocytic Leukemia – Pipeline Review, H1 2012 || Aarkstore.com | Aarkstore.com 2012 15% Discount || Oilfield Services Industry to 2016 - Technological || Latest | Scoop.it

Global Markets Direct’s, Acute Promyelocytic Leukemia - Pipeline Review, H1
2012, provides an overview of the Acute Promyelocytic Leukemia therapeutic
pipeline.

Aarkstore.com announces, The Latest  market research report is available in its vast collection:


Acute Promyelocytic Leukemia – Pipeline Review, H1 2012

http://www.aarkstore.com/reports/Acute-Promyelocytic-Leukemia-Pipeline-Review-H1-2012-215224.html

RSS link of Global Markets Direct 
 http://www.aarkstore.com/feeds/Global-Markets-Direct.xml

Summary

Global Markets Direct’s, Acute Promyelocytic Leukemia - Pipeline Review, H1 2012, provides an overview of the Acute Promyelocytic Leukemia therapeutic pipeline. This report provides information on the therapeutic development for Acute Promyelocytic Leukemia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Acute Promyelocytic Leukemia. Acute Promyelocytic Leukemia - Pipeline Review, H1 2012 is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for Acute Promyelocytic Leukemia.
- A review of the Acute Promyelocytic Leukemia products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.

Table of contents:

List of Tables 5
List of Figures 5
Introduction 6
Global Markets Direct Report Coverage 6
Acute Promyelocytic Leukemia Overview 7
Therapeutics Development 8
An Overview of Pipeline Products for Acute Promyelocytic Leukemia 8
Acute Promyelocytic Leukemia Therapeutics under Development by Companies 10
Acute Promyelocytic Leukemia Therapeutics under Investigation by Universities/Institutes 11
Late Stage Products 13
Comparative Analysis 13
Mid Clinical Stage Products 14
Comparative Analysis 14
Early Clinical Stage Products 15
Comparative Analysis 15
Pre-Clinical Stage Products 16
Comparative Analysis 16
Acute Promyelocytic Leukemia Therapeutics – Products under Development by Companies 17
Acute Promyelocytic Leukemia Therapeutics – Products under Investigation by Universities/Institutes 18
Companies Involved in Acute Promyelocytic Leukemia Therapeutics Development 19
Telik, Inc. 19
TMRC Co., Ltd. 20
Acute Promyelocytic Leukemia – Therapeutics Assessment 21
Assessment by Combination Products 22
Assessment by Route of Administration 23


List of Figures

List of Tables are also include.

 

For more related Reports Plz follow The link:

Pipeline Review, H1 2012
http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H1 2012&PubId=&pagenum=1



Acute Promyelocytic Leukemia – Pipeline Review, H1 2012

Meningococcemia (Meningococcal Infections) – Pipeline Review, H1 2012

Diabetic Neuropathic Pain – Pipeline Review, H1 2012

Streptococcus Pneumoniae (Pneumococcus) Infections – Pipeline Review, H1 2012

Premature Labor (Tocolysis) – Pipeline Review, H1 2012

Wilms Tumor (Nephroblastoma) – Pipeline Review, H1 2012

Dry (Atrophic) Macular Degeneration – Pipeline Review, H1 2012

Chondrosarcoma – Pipeline Review, H1 2012

Cellulitis – Pipeline Review, H1 2012

Left Ventricular Dysfunction – Pipeline Review, H1 2012

Adenovirus Infections – Pipeline Review, H1 2012

Abscess – Pipeline Review, H1 2012

 

 

Search More Reports Related to This Category :
 

Pharmaceuticals and Healthcare 
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and Healthcare&PubId=&pagenum=1


You can also request for sample page of above mention reports on sample@aarkstore.com





For More details Plz do contact :

Aarkstore Enterprise

Lavanya

Phone:08149852585

Email: enquiry@aarkstore.com

more...
No comment yet.
Scooped by Aarkstore.com
Scoop.it!

Aarkstore Aarkstore 2012 10% Discount || Down Stream Processing in Biopharmaceuticals - Increased || Aarkstore.com

Aarkstore Aarkstore 2012 10% Discount || Down Stream Processing in Biopharmaceuticals - Increased || Aarkstore.com | Aarkstore.com 2012 15% Discount || Oilfield Services Industry to 2016 - Technological || Latest | Scoop.it

Company's report, “Down Stream Processing in Biopharmaceuticals - Increased Demand for Biologics Drives Improvement in Cost-effective Purification Technologies”,...

Aarkstore.com announces, The Latest  market research report is available in its vast collection:


Down Stream Processing in Biopharmaceuticals - Increased Demand for Biologics Drives Improvement in Cost-effective Purification Technologies


http://www.aarkstore.com/reports/Down-Stream-Processing-in-Biopharmaceuticals-Increased-Demand-for-Biologics-Drives-Improvement-in-Cost-effective-Purification-Technologies-215814.html

RSS Link of GBI Research 
 http://www.aarkstore.com/feeds/GBI.xml

Company announces 15% discount on this report.

Discount till 31th July 2012


Downstream Processing in Biopharmaceuticals - Increased Demand for Biologics Drives Improvement in Cost -effective Purification Technologies

Summary

Company's report, “Down Stream Processing in Biopharmaceuticals - Increased Demand for Biologics Drives Improvement in Cost-effective Purification Technologies”, provides the key data and analyzes the major challenges and drivers for the downstream industry. The report also analyzes the strengths, weaknesses of and opportunities for the stakeholders in the downstream processing of biopharmaceuticals. The report also discusses the key market drivers and barriers for the growth of biomanufacturing in the pharmaceutical and biotech industry. The report is based on proprietary databases, primary and secondary research and in-house analysis by Company’s team of industry experts to provide a comprehensive view of the Down Stream Processing in Biopharmaceuticals.

Scope

The scope of this report includes:
•Opportunities and challenges for manufacturers of Biopharmaceuticals in the pharmaceuticals industry
•Market revenues and forecasts for Down Stream Processing in the global pharmaceutical industry from 2009 to 2016.
•The key geographies including the US, Europe, Japan and Emerging Hotspots such as India, Singapore and China.

Table of contents:

1.1 List of Tables
1.2 List of Figures
2 Downstream Processing: Introduction
2.1 GBI Research Report Guidance
3 Downstream Processing - Market Overview
3.1 Overview of Biopharmaceuticals
3.1.1 Cytokines
3.1.2 Enzymes
3.1.3 Hormones
3.1.4 Clotting Factors
3.1.5 Vaccines
3.1.6 Monoclonal Antibodies
3.1.7 Cell Therapies
3.1.8 Antisense Drugs
3.1.9 Peptide Therapeutics
3.2 Overview of Downstream Processing in Biopharmaceuticals
3.2.1 A Typical Downstream Processing:
3.2.2 Major Check Point during Down Stream Processing
3.3 Overview of Downstream Industry
4 Downstream Processing : Role of Downstream Processing in the Biopharmaceutical Industry
4.1 Comparison of Upstream Processing and Downstream Processing
4.2 Major Reagents, Reagent Suppliers and Reagent Market Related To Downstream Processing
4.2.1 Major Reagents

List of Figures

List of Tables are also include.


For more DISCOUNT  related Reports Plz follow The link:

Contract Research Organizations (CROs) Market to 2018 - Public-Private Partnerships to Strengthen Research Capacities and Advance Clinical Development Programs

Ophthalmic Devices Market to 2017 - Glaucoma and Cataract Surgery Devices, Minimally Invasive Procedures in Ophthalmic Surgery to Drive the Ophthalmic Surgery Market

Down Stream Processing in Biopharmaceuticals - Increased Demand for Biologics Drives Improvement in Cost-effective Purification Technologies

Offshore Rig Construction Market to 2015 and Current Rig Deployment Scenario - Acquisition of Rivals a Prominent Strategic Option

Floating Production Storage and Offloading (FPSO) and Floating Storage and Offloading (FSO) Industry to 2016 - Rise of Deepwater Hydrocarbon Production Leading to Industry Growth

 

Search More Reports Related to This Category :

Pharmaceuticals and Healthcare
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and Healthcare&PubId=&pagenum=1


 

Pharmaceutical Supply Chain in the US - Advances in RFID and ePedigree Systems to Limit Drug Counterfeits

Emerging Pharmaceutical Market in Brazil - Regulatory Framework Forces MNCs to Partner with Local Players Resulting in Profit and Control Sharing

Direct to Consumer (DTC) Advertising in Pharmaceuticals - Current and Future Market Outlook, Regulatory Landscape and Case Studies


You can also request for sample page of above mention reports on sample@aarkstore.com





For More details Plz do contact :

Aarkstore Enterprise

Lavanya

Phone:08149852585

Email: enquiry@aarkstore.com

more...
No comment yet.
Scooped by Aarkstore.com
Scoop.it!

Aarkstore Aarkstore 2012 10% Discount || Ophthalmic Devices Market to 2017 - Glaucoma || Aarkstore.com

Aarkstore Aarkstore 2012 10% Discount || Ophthalmic Devices Market to 2017 - Glaucoma || Aarkstore.com | Aarkstore.com 2012 15% Discount || Oilfield Services Industry to 2016 - Technological || Latest | Scoop.it

Company’s report, “Ophthalmic Devices Market to 2017 - Glaucoma and Cataract Surgery Devices, Minimally Invasive Procedures in Ophthalmic Surgery to Drive the Ophthalmic Surgery Market”...

Aarkstore.com announces, The Latest  market research report is available in its vast collection:


Ophthalmic Devices Market to 2017 - Glaucoma and Cataract Surgery Devices, Minimally Invasive Procedures in Ophthalmic Surgery to Drive the Ophthalmic Surgery Market

http://www.aarkstore.com/reports/Ophthalmic-Devices-Market-to-2017-Glaucoma-and-Cataract-Surgery-Devices-Minimally-Invasive-Procedures-in-Ophthalmic-Surgery-to-Drive-the-Ophthalmic-Surgery-Market-215813.html

RSS Link of GBI Research 
http://www.aarkstore.com/feeds/GBI.xml

Company announces 10% discount on this report.

Discount till 31th July 2012


Company’s report, “Ophthalmic Devices Market to 2017 - Glaucoma and Cataract Surgery Devices, Minimally Invasive Procedures in Ophthalmic Surgery to Drive the Ophthalmic Surgery Market” provides key data, information and analysis on the global ophthalmic devices market. The report provides market landscape, competitive landscape and market trends information on six ophthalmic devices market categories: cataract surgery devices, refractive surgery devices, vision care, ophthalmic diagnostic equipment, vitreo retinal surgery devices and glaucoma surgery devices. It provides comprehensive information on the key trends affecting these categories and key analytical content on the market dynamics. The report also reviews the competitive landscape and gives detailed analysis of the pipeline products in each category. It reviews details regarding important merger and acquisition deals that have taken place in the ophthalmic devices market. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Company’s team of industry experts.

Scope

• Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
• The market size is given for six ophthalmic devices equipment market categories: cataract surgery devices, refractive surgery devices, vision care, ophthalmic diagnostic equipment, vitreo retinal surgery devices and glaucoma surgery devices.
• Annualized market revenues data for 2003–2010 and forecasts for 2010–2017.
• Qualitative analysis of key market trends, market drivers, and restraints by each category within the ophthalmic devices market.

Table of contents:

1 Table Of Contents
1 Table Of Contents 2
1.1 List of Tables 8
1.2 List of Figures 11
2 Executive Summary 13
2.1 Global Ophthalmic Device Market Forecast to Increase at a CAGR of 4% During the Period 2010–2017 13
2.2 Vision Care Category to Continue to be the Largest Category in the Global Ophthalmic Devices Market 13
2.3 Essilor International and Johnson & Johnson Vision Care to Dominate the Global Ophthalmic Devices Market 14
3 Introduction 16
3.1 GBI Research Guidance 16
4 Ophthalmic Devices: Market Characterization 18
4.1 Global Ophthalmic Devices Market, Revenue ($m), 2003 – 2010 18
4.2 Global Ophthalmic Devices Market, Revenue ($m), 2010 – 2017 19
4.3 Global Ophthalmic Devices Market, Key Company Share (%), 2010 21
4.4 Global Ophthalmic Devices Market, Key Trends 23
4.4.1.1 Application of Femtosecond Laser in Cataract Surgery 23

List of Figures

List of Tables are also include.



For more DISCOUNT  related Reports Plz follow The link:

Contract Research Organizations (CROs) Market to 2018 - Public-Private Partnerships to Strengthen Research Capacities and Advance Clinical Development Programs

Ophthalmic Devices Market to 2017 - Glaucoma and Cataract Surgery Devices, Minimally Invasive Procedures in Ophthalmic Surgery to Drive the Ophthalmic Surgery Market

Down Stream Processing in Biopharmaceuticals - Increased Demand for Biologics Drives Improvement in Cost-effective Purification Technologies

Offshore Rig Construction Market to 2015 and Current Rig Deployment Scenario - Acquisition of Rivals a Prominent Strategic Option

Floating Production Storage and Offloading (FPSO) and Floating Storage and Offloading (FSO) Industry to 2016 - Rise of Deepwater Hydrocarbon Production Leading to Industry Growth

 

Search More Reports Related to This Category :

Medical Devices
http://www.aarkstore.com/search/viewresults.asp?search=Medical Devices&PubId=&pagenum=1

 

The Future of Orthopedic Implants, Analysis and Forecasts to 2016 - Joint Reconstruction and Spinal Implants Creating Growth Opportunities

Spinal Surgery Devices Market - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 - Motion Preserving Spinal Non-Fusion Procedures to Drive Long Term Growth

Orthopedic Devices Market in the Emerging Countries (China, India, Brazil) - Greater Focus on Minimally Invasive Orthopedic Procedures to Drive the Market


You can also request for sample page of above mention reports on sample@aarkstore.com





For More details Plz do contact :

Aarkstore Enterprise

Lavanya

Phone:08149852585

Email: enquiry@aarkstore.com

more...
No comment yet.
Scooped by Aarkstore.com
Scoop.it!

2012 || Pharmaceuticals || Gestational Diabetes – Pipeline Review, H1 2012 || Aarkstore.com

2012 || Pharmaceuticals || Gestational Diabetes – Pipeline Review, H1 2012 || Aarkstore.com | Aarkstore.com 2012 15% Discount || Oilfield Services Industry to 2016 - Technological || Latest | Scoop.it

Global Markets Direct’s, Gestational Diabetes - Pipeline Review, H1 2012,
provides an overview of the Gestational Diabetes therapeutic pipeline.

Aarkstore.com announces, The Latest  market research report is available in its vast collection:


Gestational Diabetes – Pipeline Review, H1 2012

http://www.aarkstore.com/reports/Gestational-Diabetes-Pipeline-Review-H1-2012-215218.html

RSS link of Global Markets Direct 
 http://www.aarkstore.com/feeds/Global-Markets-Direct.xml


Summary

Global Markets Direct’s, Gestational Diabetes - Pipeline Review, H1 2012, provides an overview of the Gestational Diabetes therapeutic pipeline. This report provides information on the therapeutic development for Gestational Diabetes, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Gestational Diabetes. Gestational Diabetes - Pipeline Review, H1 2012 is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for Gestational Diabetes.
- A review of the Gestational Diabetes products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.

Table of contents:

List of Tables 3
List of Figures 3
Introduction 4
Global Markets Direct Report Coverage 4
Gestational Diabetes Overview 5
Therapeutics Development 6
An Overview of Pipeline Products for Gestational Diabetes 6
Gestational Diabetes Therapeutics under Investigation by Universities/Institutes 8
Late Stage Products 9
Comparative Analysis 9
Gestational Diabetes Therapeutics – Products under Investigation by Universities/Institutes 10
Assessment by Combination Products 11
Assessment by Route of Administration 12
Assessment by Molecule Type 14
Drug Profiles 16
Liraglutide + Metformin - Drug Profile 16
Product Description 16
Mechanism of Action 16
R;D Progress 16
Metformin + Glyburide - Drug Profile 17
Product Description 17
Mechanism of Action 17
R;D Progress 17
Gestational Diabetes Therapeutics - Dormant Products 18
Appendix 19
Methodology 19
Coverage 19
Secondary Research 19
Primary Research 19
Expert Panel Validation 19
Contact Us 20
Disclaimer 20

List of Figures

List of Tables are also include.

 

For more related Reports Plz follow The link:

Pipeline Review, H1 2012
http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H1 2012&PubId=&pagenum=1



Seasonal Allergic Rhinitis – Pipeline Review, H1 2012

Reperfusion Injury – Pipeline Review, H1 2012

Ulcers – Pipeline Review, H1 2012

Venous Leg Ulcers – Pipeline Review, H1 2012

Gestational Diabetes – Pipeline Review, H1 2012

Gastroesophageal (GE) Junction Carcinomas – Pipeline Review, H1 2012

Fanconi Anemia – Pipeline Review, H1 2012

Hepatitis D – Pipeline Review, H1 2012

Adult Malignant Glioma – Pipeline Review, H1 2012

Hemorrhage – Pipeline Review, H1 2012

Insulin Resistance – Pipeline Review, H1 2012

Adenovirus Infections – Pipeline Review, H1 2012

Abscess – Pipeline Review, H1 2012

 

 

Search More Reports Related to This Category :
 

Pharmaceuticals and Healthcare 
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and Healthcare&PubId=&pagenum=1


You can also request for sample page of above mention reports on sample@aarkstore.com





For More details Plz do contact :

Aarkstore Enterprise

Lavanya

Phone:08149852585

Email: enquiry@aarkstore.com

more...
No comment yet.